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Stroke is the third commonest cause of death worldwide and
over two-thirds of those deaths occur in developing regions such
as sub-Saharan Africa.1 Local South African vital registration
figures2 and a verbal autopsy study from the Agincourt Health
and Population Unit,3 a rural demographic surveillance site in
Limpopo province, confirm that stroke is an increasingly
important cause of death in South Africa. But most people
survive stroke and about half are disabled,4 placing an enormous
burden on the survivors, their families and the community.
The acute management of stroke has improved dramatically
ove the last decade with the introduction of stroke units, stroke
management protocols and national guidelines,3 and acute
treatments such as thrombolysis.6,7 However, the most cost-
effictive approach to management is to prevent the stroke in the
first place.8 To do this we need to reduce the individual patient’s
stroke risk factors (high-risk strategy), and reduce risk factors
throughout the population (mass strategy).
Conventional stroke risk factors are divided into those we
cannot influence such as increasing age, male gender, family
history, socio-economic status and race; and those we can
potentially influence such as hypertension, diabetes mellitus
(DM), atrial fibrillation, smoking, hypercholesterolaemia,
exessive alcohol intake, obesity, physical inactivity, and
prothrombotic factors.7 One of the most important risk factors
for recurrent stroke is prior stroke or transient ischaemic attack
(TIA). About 30% of people who have had a stroke or TIA will
have another stroke during the following 5 years; and almost
half of these will occur within 6 months to a year of the initial
event.9,10 Appropriate secondary prevention reduces this risk
significantly.11 General practitioners (GPs) play a major role in
detecting and treating modifiable risk factors and implementing
primary and secondary stroke prevention measures.
It is well established that the relative importance of risk factors
for stroke and cardiovascular disease differs between
populations.13-14 If we are to design locally appropriate strategies
to address risk factor reduction within the general practice
population to facilitate both the high-risk and practice
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Background. Incidence of stroke is increasing in sub-Saharan
Africa and stroke prevention is an essential component of
successful stroke management. General practitioners (GPs)
are well placed to manage stroke risk factors. To design
appropriate strategies for risk factor reduction we need to
know the risk factor prevalence in each of the population
groups attending GPs. The aim of this study was to establish
the prevalence of stroke risk factors in the South African
general practice population.
Method. We conducted  a multicentre, observational study of
patients attending general practice in South Africa. Two
hundred general practices were randomly selected from lists
provided by pharmaceutical representatives. Each GP
approached 50 consecutive patients aged 30 years and older.
Patients completed an information sheet and the GP
documented the patient’s risk factors. The resulting sample is
relevant if not necessarily representative in a statistical sense.
Results. A total of 9 731 questionnaires were returned out of a
possible  10 000. The mean age of particpants was 50.7 years.
Seventy-six per cent had 1 or more risk factors and 40% had 2
or more risk factors. Hypertension was the commonest risk
factor in all population groups (55%) but was highest in black
patients (59%). Dyslipidaemia was commonest in whites
(37%) and least common in blacks (5%). Diabetes was
commonest in Asians (24%) but least common in whites (8%).
Risk factors other than smoking increased with age.
Conclusion. This study provides unique data on the
prevalence of stroke risk factors in a South African general
practice population. Risk factors are common in all
population groups, but differ in distribution among the
groups. There is considerable opportunity  to reduce the
burden of stroke in South Africa through GP screening for
and treatment of risk factors.
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population, then we need to know the prevalence of risk factors
in each of the South African population groups. The aim of this
study was to establish the prevalence of the most important
stroke risk factors in the South African general practice
population to facilitate both the high-risk and population
approaches to stroke prevention.  
Methods
We conducted a multicentre, observational study of patients
attending general practice in South Africa.
Participant selection
Seventeen pharmaceutical company representatives
countrywide were asked to submit a list of the names of 40 
GPs in their respective areas (680 practices in total nationally). In
order to include 200 general practices, we randomly selected  12
- 13 on each representative’s list, with a further 1 or 2 as a
backup to replace GPs who refused to participate. The GPs were
therefore not selected on the basis of any specific characteristic
that could have influenced the results.
Each consenting GP approached 50 consecutive patients aged
30 years or older to participate in the study. Patients were given
an information sheet and written consent was obtained before
including them in the study. Only demographic data were
recorded for patients who refused consent. Management of
patients with risk factors was left to the GPs’ discretion.
Risk-factor assessment and definitions
The GPs completed a 5-page questionnaire for each participating
patient during the standard consultation for which the patient
had attended the practice. The questionnaire included risk-factor
and demographic information. The patient’s most recent blood
pressure (BP) measurement was documented. We defined
hypertension as past history of  hypertension or a current
presentation with a systolic BP ≥ 140 mmHg, or a diastolic BP of
≥ 90 mmHg. The highest result in  the past 12 months for fasting
total cholesterol, high-density lipoprotein (HDL), low-density
lipoprotein (LDL), triglycerides and blood glucose were
recorded if available. We defined dyslipidaemia as a past history
of hypercholesterolaemia or a current presentation with a fasting
cholesterol level > 
5 mmol/l or LDL level > 3 mmol/l. DM was defined as a past
history of DM or a current presentation with a fasting blood
glucose level of ≥ 7 mmol/l. Current smoking status, a history of
ever having smoked, alcohol use and a history of previous
stroke or TIA were noted. A current presentation or history of
heart failure, ischaemic heart disease or venous thromboembolic
event were also recorded. We defined atrial fibrillation as a past
history of atrial fibrillation or a current presentation with atrial
fibrillation or an irregular pulse rate. Current use of medication
for cardiovascular risk factors was documented, as was a current
presentation or past history of motor, sensory, speech, or
cerebellar abnormalities, double vision, amaurosis fugax or
dizziness.
Data analysis
Data were entered in EpiInfo and analysed using Stata 8.
Descriptive statistics included the mean and standard deviations
(SDs) as well as proportion with confidence intervals (CIs). We
assessed the difference between population groups with regard
to risk factors using chi-square tests. The distribution of the
number of risk factors between the ethnic groups was compared
using a Kruskal-Wallis test with adjusment after post hoc
comparisons. We used logistical regression to determine the
odds ratios (ORs) of the different population group categories
for the various risk factors after adjusting for differences in age
and gender.
Ethics
The Medicines Control Council confirmed that no formal
approval was required other than ethics committee approval, as
no drug was to be used in the study. Ethics committee approval
was obtained from the University of Pretoria (120/2001) and
Pharma-Ethics (ICE-9490 012-ZAF)
Results
Demographics
Two hundred general practices were registered after 79 of the
randomised GPs who refused to participate had been replaced
by others in the same geographical area, as close as possible to
the original randomised practice. A total of 9 731 questionnaires
were returned. Data were available for 199 practices as 1 practice
submitted questionnaires after the deadline date. The national
distribution of participants was as follows (the percentage of the
study sample and for comparison the percentage of the total
South African population in the region are given in brackets for
each region): Gauteng/Mpumalanga 2 689 participants (29%;
25%); Western Cape 1 744 participants (19%, 10%); KwaZulu-
Natal 1 609 participants (18%, 21%); Limpopo Province 1 506
participants (17%, 12%); Central Provinces 855 participants (9%,
17%); and Eastern Cape 544 participants (6%,16%).15 Although
participating patients were widely distributed across South
Africa, the majority were seen in metropolitan cities and rural
areas were underrepresented.
Six per cent of participants (N = 618) were ineligible for
analysis because of refusal (N = 303), missing most data (N =
187), or not meeting the inclusion criteria, e.g. under 30 years of
age (N = 128). A total of 9 133 participants were therefore
included and 303 non-participants excluded because of either
patient refusal or doctor refusal to enter a particular individual.
The mean age of participants was 50.7 years (SD 13.9, range 30 -
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100 years) and 73% of the participants were in the 30 - 59-year
age range. The sex and population group distribution of
participants and non-participants (because of refusal) was
similar. Forty-five per cent of both the participants and non-
participants were male, 23% of the participants were black, 7%
coloured, 10% Asian, and 59% white; while 28% of the non-
participants were black, 7% coloured, 8% Asian and 56% white.
Not all participants had all risk factors recorded. Only 31%
had a total cholesterol reported and 40% had glucose values
reported. In contrast, 96% of all participants had BP readings
reported. Unfortunately, the proportion of tests done varied
significantly among population groups. The proportion of each
population group that had glucose values reported was as
follows: black 30%, coloured 38%, Asian 55%, and white 41% 
(p < 0.001). The proportions for total cholesterol were: black 8%,
coloured 22%, Asian 22% and white 43% (p < -0.001).
Risk factors
Seventy-six per cent of patients had 1 or more risk factors and
40% had 2 or more risk factors. There was a statistically
significant difference (p < 0.001) in the number of risk factors
between population groups. Post hoc testing showed that this
distribution was significantly different between all groups except
between the coloureds and Asians (p = 0.15, p < 0.004) required
for significance). Of the 24% with no reported risk factors, the
majority (32%) were black patients. Three or more risk factors
occurred almost as commonly in the Asian, white  and coloured
groups (11 - 14%), but far less commonly in the black group
(4%).
Table I shows the prevalence of risk factors by population
group. Figs 1 - 3 graphically compare the prevalence of
hypertension, dyslipidaemia, and a history of ever having
smoked cigarettes by age group and population group.
Hypertension is clearly the commonest risk factor in all
population groups but stands out as the major risk factor in
black patients. Logistical regression revealed that whites were
44% less likely to have hypertension than blacks even having
adjusted for age and gender (OR 0.66, 95% CI: 0.59 - 0.74). The
proportion of people still hypertensive despite treatment was
47%.
Whites were 10 times more likely to have dyslipidaemia than
those blacks for whom information was available (OR 10.2, 95%
CI: 8.3 - 12.5). As expected, DM was most common in the Asian
population (26%) but surprisingly least common in the white
population (8%). Most risk factors except cigarette smoking
increased with age.
Atrial fibrillation was commonest in the white population
(5%) followed by the coloured population (4%), and about
equally common in the black and Asian population (2%).
Current or past heart failure and venous thromboembolism were
each present in 4% of participants. Ischaemic heart disease (past
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Table I. Risk-factor prevalence (percentage) by population group, adjusted for age and gender (95% confidence intervals)
Risk factor Black Coloured Asian White Total
Hypertension 59 (57 - 61) 55 (52 - 59) 55 (52 - 58) 50 (49 - 52) 55
Diabetes mellitus 14 (12 - 15) 15 (12 - 18) 26 (23 - 29) 8  (7 - 8) 16
Dyslipidaemia 5 (4 - 6) 23 (20 - 27) 22 (19 - 25) 37 (35 - 38) 22
History of ever smoking cigarettes 21 (20 - 23) 44 (40 - 48) 26 (24 - 29) 42 (41 - 44) 33
Atrial fibrillation 2 (2 - 3) 4 (2 - 6) 2 (1 - 3) 5 (5 - 6) 3
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Fig. 1. Prevalence of hypertension by sex, age group and population
group (age group 1 = 30 - 49, age group 2 = 50 - 69, age group 
3 = 70+).
334-345  5/6/05  2:33 PM  Page 336
ORIGINAL ARTICLES
337
May 2005, Vol. 95, No. 5  SAMJ
or present) was found in 8% of whites, 7% of Asians, 5% of
coloureds and 1% of blacks. A history of previous strokes or TIA
was present in 2% of blacks and coloureds, 4% of Asians, and 5%
of whites.
Discussion
Our study provides unique data on the prevalence of stroke risk
factors in a South African general practice population. We have
found that these risk factors are common in all population
groups, but that different distributions of risk factors exist in the
various population groups. Hypertension is the single most
important risk factor.
Our study has several limitations. Although we randomly
selected general practices, the sampling was taken from lists of
GPs provided by pharmaceutical company representatives.
Representatives may have been more likely to include GPs who
were interested in stroke or cardiovascular risk factors, or more
easily accessible. The latter point explains in part why our
sample underrepresents rural practices. Although we randomly
selected practices, the proportion of various population groups
in the study does not mirror South African demographics. This
distortion probably reflects both the general practice population
in South African urban areas and our general practice selection
bias. The subjects reported in this study therefore do not
represent a true random sample of the South African population.
In addition the study could not be analysed formally as a survey
(using probability weighting for instance) because data on the
exact number of patients and ethnic group proportions seen in
each practice were not available. Furthermore, we did not take
into account the fact that subjects in each practice could be
regarded as belonging to a cluster in the analysis. These analysis
limitations should not influence the point estimates much, but
our CIs may appear more precise than they would have done
with a survey analysis.
A major limitation of the study is that not all participants had
all risk factors recorded, and the small numbers of glucose and
total cholesterol values available, particularly for black and
coloured participants. The percentages of reported risk factors
were calculated on the total number of participants in each
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Fig. 3. Prevalence of cigarette smoking by sex, age group and
population group (age group 1 = 30 - 49, age group 2 = 50 - 69,
age group 3 = 70+).
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Fig. 2. Prevalence of dyslipidaemia by sex, age group and
population group (age group 1 = 30 - 49, age group 2 = 50 - 69,
age group 3 = 70+).
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population group. We are therefore likely to have under-
estimated hypercholesterolaemia and DM. Our definition of
hypertension included patients with one BP reading ≥ 140
mmHg systolic or ≥ 90 mmHg diastolic. We may therefore have
included patients who did not have persistent hypertension and
as such have overestimated the prevalence of hyper-tension.
Despite these limitations, this study provides useful information
on the prevalence of stroke risk factors in a large sample of
South Africans attending GPs.
Hypertension is a major risk factor for stroke, with stroke risk
almost doubling with each 7.5 mmHg increase in diastolic BP.16
There is an even stronger association with systolic hypertension.7
We found an alarmingly high prevalence of hypertension in all
population groups. Indeed, every second patient over the age of
30 years in our general practice sample had hypertension. This
figure is much higher than the prevalence of hypertension —
21% for men and women over the age of 15 years when BP was
defined as ≥ 140 mmHg systolic or ≥ 90 mmHg diastolic or on
treatment — reported in the South African Demographic and
Health Surveillance Survey (SADHS) in 1998.17 The difference
between the two studies is probably explained by the older age
of patients in our study, and a different definition of
hypertension used. While we used the same levels of systolic
and diastolic BP to define hypertension, our definition included
anyone with a history of hypertension. However, our population
also has a much higher prevalence of hypertension than that
found in Australians (44%, 95% CI: 43% - 45%)18 in a study using
very similar methodology to this study. The proportion of
people still hypertensive despite being on antihypertensive
agents was alarmingly high in our study (47%).
Despite the similarity in prevalence of hypertension between
blacks and whites, when we adjusted for age and gender, whites
were 44% less likely to have hypertension than blacks. This
difference is also found in the USA, where African-Americans
have a higher prevalence of hypertension and develop
hypertension at a younger age than their white counterparts.19
The Asian population in South Africa is known to have a high
prevalence of DM20 and a self-reported prevalence of 8.5% was
found in the Demographic and Health Survey.20 Our very high
prevalence of 24% probably reflects the bias of a general practice
population rather than a true reflection of the population.
The overall prevalence of cigarette smoking in our study
(21%) was similar to that found previously in South Africa
(25%).21 Among males there was little variation in the prevalence
of smoking across population groups. Among females, who
generally smoked less, the prevalence was low in Asian and
black patients, but much higher in young coloureds and whites.
The alarmingly high prevalence of smoking in the coloured
population has also been noted before.21 While the government
has implemented strict controls on advertising and smoking in
public places, and smoking in South Africa is thought to be
decreasing, specific attention should be paid to decreasing this
risk factor in target groups.21
While the prevalence of dyslipidaemia among whites was
similar to that found in caucasian populations elsewhere,18 it was
markedly lower in the black population, and intermediate in the
Asian and coloured populations. This distribution of
dyslipidaemia in the South African population is well
documented,22,23 but it is unlikely to remain constant for long. In
the THUSA (Transition and Health during Urbanisation of South
Africans) study, urban black professionals had significantly
higher total serum cholesterol levels than their rural
counterparts,24 suggesting that increasing exposure to lifestyle
risk factors will change this pattern.
Our study has several important implications. Stroke and
vascular risk factors are common in the South African
population attending GPs. The smaller burden in terms of
number of risk factors in the black population group should not
be of any comfort. If the anticipated health transition with its
associated increase in cardiovascular risk factors, stroke and
cardiovascular disease materialises, then this burden is likely to
increase dramatically.25,26 South Africa faces the enormous
challenge of managing diseases of poverty, violence, and
HIV/AIDS. Cardiovascular disease already adds to the load2
and our findings highlight the considerable opportunity that
exists to reduce that burden through GP screening and
treatment.
The Southern African Stroke Foundation aims to increase
health professional awareness of stroke and its risk factors in
order to prevent stroke in high-risk individuals, and to raise
awareness and lower risk in the general population. Our study
provides baseline data against which progress in risk factor
management can be measured.
More results and the full text version of this article are available
on the Southern African Hypertension Society’s webpage:
http://www.hypertension.org.za
Servier Laboratories South Africa supported this work financially,
but had no influence over the analysis or interpretation of the study
results.
We are grateful to the many GPs who participated, and the
pharmaceutical representatives who facilitated the study. The
members of the Southern African Stroke Foundation Research
Committee were involved in the study concept and design.
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Routinely available cotrimoxazole prophylaxis and
occurrence of respiratory and diarrhoeal morbidity in
infants born to HIV-infected mothers in South Africa
Anna Coutsoudis, Kubendran Pillay, Elizabeth Spooner, Hoosen M Coovadia, Lucy Pembrey, Marie-Louise Newell
Objectives. To examine the influence of cotrimoxazole (CTM)
prophylaxis on incidence of lower respiratory tract infections
(LRTIs) and diarrhoea.
Design.  A prospective observational cohort study.  Morbidity
and feeding data on infants born to HIV-infected mothers
were collected routinely at clinic visits at 1 week, 6 weeks and
3 months, and 3-monthly thereafter, with blood drawn for
determining HIV status. 
Setting. Two hospitals in Durban, South Africa.  In one
hospital (King Edward VIII Hospital), infants born to HIV-
infected mothers recieved CTM prophylaxis and in the other
(McCord Hospital) infants did not receive CTM prophylaxis.  
Subjects. Infants born to HIV-infected mothers.
Outcome measures.  Incidence of LRTI and diarrhoea.
Results. In multivariate analysis controlling for breast-feeding
status, number of clinic visits and HIV infection status, HIV-
infected infants with access to CTM prophylaxis had a
significantly lower incidence of LRTI (82%) than those
without access to prophylaxis.  However in HIV-uninfected
infants, this was not the case. CTM prophylaxis was
associated with a non-significant increased risk for diarrhoea
in both infected (odds ratio (OR) 1.58, p = 0.45) and unin-
fected infants (OR 1.52, p = 0.10).  
Conclusions. This observational study confirms current
thinking that CTM prophylaxis is protective against LRTIs in
HIV-infected children.  However, because of a possible
association between CTM prophylaxis and an increased risk
of diarrhoea, HIV status of infants should be determined as
early as possible in order to prevent unnecessary exposure of
uninfected infants to CTM prophylaxis, while further studies
to quantify both beneficial and adverse effects of CTM
prophylaxis are undertaken.
S Afr Med J 2005; 95: 339-345
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